Clinical Trial Update: Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pharmacokinetics and adherence using MEMS in HIV-naive patients treated with Reyataz (atazanavir) once daily with Norvi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• REYATAZ (atazanavir)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED